股票 › DMRA
Damora 制药 DMRA
美股市值排名 #2960
$23.70 +$1.84 (+8.42%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $23.70 0.00%
开盘$22.01
昨收$21.86
当日区间$21.13 – $24.25
成交量360.5K
市值$1.47B
市盈率（TTM）13.9
股息率–
DMRA 相关新闻
匹配 Damora Therapeutics 或代码 DMRA 的头条新闻，按最新排序。
- Wedbush Maintains Damora Therapeutics(DMRA.US) With Buy Rating, Maintains Target Price $40
- Guggenheim Maintains Damora Therapeutics(DMRA.US) With Buy Rating, Raises Target Price to $60 正面
- LifeSci Capital Maintains Damora Therapeutics(DMRA.US) With Buy Rating, Maintains Target Price $45
- H.C. Wainwright Maintains Damora Therapeutics(DMRA.US) With Buy Rating, Maintains Target Price $45
- A Quick Look at Today's Ratings for Damora Therapeutics(DMRA.US), With a Forecast Between $40 to $50
- A Quick Look at Today's Ratings for Damora Therapeutics(DMRA.US), With a Forecast Between $40 to $45
- Wedbush Maintains Damora Therapeutics(DMRA.US) With Buy Rating, Raises Target Price to $40 正面
- Jefferies Initiates Damora Therapeutics(DMRA.US) With Buy Rating, Announces Target Price $50
- TD Cowen Initiates Damora Therapeutics(DMRA.US) With Buy Rating
- RBC Capital Maintains Damora Therapeutics(DMRA.US) With Buy Rating, Maintains Target Price $40
- Wedbush Maintains Damora Therapeutics(DMRA.US) With Buy Rating, Maintains Target Price $35
- Guggenheim Maintains Damora Therapeutics(DMRA.US) With Buy Rating, Maintains Target Price $40
- TD Cowen Maintains Damora Therapeutics(DMRA.US) With Buy Rating
- H.C. Wainwright Initiates Damora Therapeutics(DMRA.US) With Buy Rating, Announces Target Price $45
- Wedbush Initiates Damora Therapeutics(DMRA.US) With Buy Rating, Announces Target Price $35
暂无评论——快来第一个聊聊 DMRA。
登录后参与讨论。